Non-alcoholic Fatty Liver Disease
📧 Sign up to get email alerts when something new happens for Non-alcoholic Fatty Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-01-26Clinical Trial Update: Study of Various Treatments in Non-alcoholic Fatty Liver Disease (NAFLD) Patients Who Have Aspects of Non-alcoholic Steatohepatitis (NASH) [Phase 2]
Phase 2 trial update for various treatments in NAFLD with aspects of NASH; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2022-12-20Clinical Trial Update: Follow-up of NAFLD Patients With MRI-PDFF [Phase 4]
A Phase 4 follow-up trial evaluating NAFLD in patients with Type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2022-11-14Clinical Trial Update: Effectiveness of Inactive Vitamin D Supplementation in Non-Alcoholic Fatty Liver Disease Patients [Phase 3]
Phase 3 trial assessing inactive vitamin D supplementation for effectiveness in non-alcoholic fatty liver disease.
-
CLINICAL_TRIALS trial_result · 2022-10-06Clinical Trial Update: Oltipraz for Liver Fat Reduction in Patients With Non-alcoholic Fatty Liver Disease Except for Liver Cirrhosis [Phase 3]
Phase 3 clinical trial update for oltipraz in reducing liver fat in non-alcoholic fatty liver disease (excluding cirrhosis) has completed.
-
CLINICAL_TRIALS trial_result · 2022-08-30Clinical Trial Update: Comparison of the Effects of Metformin and Pioglitazone on Liver Enzymes and Ultrasound Changes in Non-Diabetic Non-Alcoholic Fatty Liver [Phase 3]
Phase 3 trial comparing metformin versus pioglitazone on liver enzymes and ultrasound changes in non-diabetic non-alcoholic fatty liver dise…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-05-31Clinical Trial Update: A Study to Evaluate Safety and Pharmacodynamic Efficacy of 0382 in Obese Subjects With NAFLD/NASH. [Phase 2]
Phase 2 clinical trial assessing safety and pharmacodynamic efficacy of 0382 in adults with NAFLD/NASH has completed with results posted in …
-
CLINICAL_TRIALS trial_result · 2022-05-11Clinical Trial Update: A Double-blind Study to Assess 2 Doses of an Investigational Product for 16 Weeks in Participants With Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus [Phase 2]
Phase 2 double-blind trial evaluating two doses of an investigational product for 16 weeks in adults with non-alcoholic steatohepatitis and …
-
CLINICAL_TRIALS trial_result · 2022-05-05Clinical Trial Update: Fish Oil and Nonalcoholic Fatty Liver Disease (NAFLD) Study [NA]
Clinical trial on fish oil for nonalcoholic fatty liver disease has completed; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-05-03Clinical Trial Update: Structured Mobile Technology Based Lifestyle Program vs Usual Care for Patients With Non-alcoholic Fatty Liver Disease [NA]
A completed clinical trial comparing a structured mobile technology–based lifestyle program to usual care for non-alcoholic fatty liver dise…
-
CLINICAL_TRIALS trial_result · 2022-04-21Clinical Trial Update: Safety And Efficacy Study Of Orally Administered Epeleuton In Patients With NAFLD [Phase 2]
Phase 2 clinical trial update evaluating safety and efficacy of oral epeleuton in non-alcoholic fatty liver disease has been completed with …
-
CLINICAL_TRIALS trial_result · 2022-04-04Clinical Trial Update: Use of a Novel Drug in People With Non-alcoholic Steatohepatitis (NASH) or Non-alcoholic Fatty Liver Disease (NAFLD) [Phase 2]
A Phase 2 trial investigating a novel drug for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) has termin…
-
CLINICAL_TRIALS trial_result · 2022-02-02Clinical Trial Update: Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis [Phase 2]
Phase 2 rollover study of cenicriviroc for liver fibrosis in nonalcoholic steatohepatitis was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2021-11-03Clinical Trial Update: A Prospective Study of HBV Immunity and HBV Vaccination in Patients With NAFLD in Canada
Completed prospective study evaluating HBV immunity and vaccination in patients with non-alcoholic fatty liver disease in Canada; results po…
-
CLINICAL_TRIALS research · 2021-10-12Clinical Trial Update: The Effect of Protein-enriched Diet on Body Composition and Appetite [NA]
A completed clinical trial studying the effect of a protein-enriched diet on body composition and appetite in overweight or obese individual…
-
CLINICAL_TRIALS trial_result · 2021-09-27Clinical Trial Update: A Phase 2 Study of Elobixibat in Adults With NAFLD or NASH [Phase 2]
A Phase 2 trial of elobixibat in adults with nonalcoholic fatty liver disease or nonalcoholic steatohepatitis has completed, with results po…
-
CLINICAL_TRIALS trial_result · 2021-09-23Clinical Trial Update: Study of the Safety and Tolerability of AXA1957 in Adolescent Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD) [NA]
Clinical trial update for AXA1957 in adolescents with NAFLD; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2021-07-15Clinical Trial Update: Intra-Individual Reproducibility of the Non-Invasive Assessment of the Portal Circulation [NA]
Completed clinical trial assessing intra-individual reproducibility of non-invasive portal circulation assessment using HepQuant technology;…
-
CLINICAL_TRIALS trial_result · 2021-07-02Clinical Trial Update: SGLT2 Inhibitor Versus Sulfonylurea on Type 2 Diabetes With NAFLD [Phase 4]
Phase 4 trial comparing an SGLT2 inhibitor with a sulfonylurea in type 2 diabetes patients with non-alcoholic fatty liver disease has comple…
-
CLINICAL_TRIALS research · 2021-07-02Clinical Trial Update: Study of the Safety and Tolerability of AXA1125 and AXA1957 in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD) [NA]
Clinical trial update describing the safety and tolerability study of AXA1125 and AXA1957 in subjects with non-alcoholic fatty liver disease…
-
CLINICAL_TRIALS trial_result · 2021-05-27Clinical Trial Update: How Does Dietary Carbohydrate Influence the Formation of an Atherogenic Lipoprotein Phenotype (ALP)? [NA]
A completed clinical trial examining how dietary carbohydrate affects the formation of an atherogenic lipoprotein phenotype in NAFLD.
-
CLINICAL_TRIALS trial_result · 2021-04-29Clinical Trial Update: Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseases [Phase 4]
Phase 4 clinical trial update evaluating efficacy and safety of Evoglitin in patients with type 2 diabetes and non-alcoholic fatty liver dis…
-
CLINICAL_TRIALS trial_result · 2021-04-26Clinical Trial Update: Safety and Tolerability of VK2809 in Patients With Primary Hypercholesterolemia and Non-Alcoholic Fatty Liver Disease [Phase 2]
Phase 2 clinical trial update assessing safety and tolerability of VK2809 in patients with primary hypercholesterolemia and non-alcoholic fa…
-
CLINICAL_TRIALS trial_result · 2021-04-09Clinical Trial Update: A Study of Pemafibrate in Patients With Nonalcoholic Fatty Liver Disease (NAFLD) [Phase 2]
Phase 2 clinical trial update for pemafibrate in non-alcoholic fatty liver disease has completed.
-
CLINICAL_TRIALS research · 2021-03-26Clinical Trial Update: Effects of Dietary Fructose on Gut Microbiota and Fecal Metabolites in Obese Men and Postmenopausal Women: A Pilot Study [NA]
Pilot study examining how dietary fructose affects gut microbiota and fecal metabolites in obese men and postmenopausal women.
-
CLINICAL_TRIALS trial_result · 2021-03-17Clinical Trial Update: Fucoidan Improves the Metabolic Profiles of Patients With Non-alcoholic Fatty Liver Disease (NAFLD) [NA]
Clinical trial update reports that fucoidan may improve metabolic profiles in patients with non-alcoholic fatty liver disease (NAFLD).